Sera Prognostics Adds New Senior Executive
September 22, 2021
Sera Prognostics Inc., The Pregnancy Company™ (NASDAQ: SERA) will add a new doc to the team. Dr. Michael R. Foley has been appointed to the position of Chief Medical Officer starting in January 2022.
Salt Lake City-based Sera Prognostics focuses on neonatal health as well as maternal health using biomarker information. Using PreTRM® test reports, physicians can predict individualized risk of spontaneous premature delivery in a pregnancy, making early proactive intervention possible.
Dr. Foley has previously worked in a private maternal-fetal medicine practice for over 20 years as well as Chairman of Obstetrics and Gynecology at the University of Arizona College of Medicine Phoenix/Banner Good Samaritan Regional Medical Center, where he has served for over 1o years.
Recent News
- BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)
- Canary Speech Achieves HITRUST e1 Certification for Voice Biomarker Platform
- Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
- Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)
- GE HealthCare’s Economic Impact Across Utah
- RefloDx Wins Trans Atlantic Angel Grand Prize